POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,368 | +35.2% | 13,600 | 0.0% | 0.00% | – |
| Q2 2023 | $23,936 | -38.3% | 13,600 | +7.9% | 0.00% | – |
| Q1 2023 | $38,808 | -32.2% | 12,600 | +16.7% | 0.00% | – |
| Q4 2022 | $57,240 | -20.5% | 10,800 | -46.8% | 0.00% | – |
| Q3 2022 | $72,000 | +38.5% | 20,304 | 0.0% | 0.00% | – |
| Q2 2022 | $52,000 | -45.8% | 20,304 | -5.4% | 0.00% | – |
| Q1 2022 | $96,000 | -33.8% | 21,473 | +0.8% | 0.00% | – |
| Q4 2021 | $145,000 | +88.3% | 21,304 | +102.8% | 0.00% | – |
| Q3 2021 | $77,000 | -26.7% | 10,504 | 0.0% | 0.00% | – |
| Q2 2021 | $105,000 | +5.0% | 10,504 | 0.0% | 0.00% | – |
| Q1 2021 | $100,000 | – | 10,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $7,605,000 | 1.52% |
| Privium Fund Management (UK) Ltd | 48,470 | $353,000 | 0.38% |
| Pentwater Capital Management LP | 4,967,227 | $36,211,000 | 0.37% |
| J. Goldman & Co LP | 301,391 | $2,197,000 | 0.11% |
| Perceptive Advisors | 787,745 | $5,743,000 | 0.08% |
| KNOTT DAVID M | 29,566 | $216,000 | 0.08% |
| Virtus ETF Advisers LLC | 23,082 | $168,000 | 0.07% |
| Altium Capital Management LP | 32,238 | $235,000 | 0.06% |
| Advisory Services Network, LLC | 268,290 | $1,956,000 | 0.06% |
| MCF Advisors LLC | 66,185 | $482,000 | 0.05% |